dextrothyroxine has been researched along with framycetin in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (95.24) | 18.7374 |
1990's | 1 (4.76) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Levy, RI | 2 |
Clopath, P; Dicato, MA | 1 |
Diament, J; Forti, N; Giannini, SD | 1 |
Augustin, J; Greten, H; Klose, G; Middelhoff, G; Mordasini, R | 1 |
Ritland, S | 1 |
Sirtori, C | 1 |
Gotto, AM; Yeshurun, D | 1 |
Blum, CB; Levy, RI | 1 |
Perry, RS | 1 |
Gotto, AM; Jones, PH; Scott, LW | 1 |
Parker, F | 1 |
Krikler, DM | 1 |
Connor, WE | 1 |
Lewis, B | 1 |
Canzler, H | 1 |
Schade, RW | 1 |
Gries, FA; Hein, H; Koschinsky, T; Vogelberg, KH | 1 |
8 review(s) available for dextrothyroxine and framycetin
Article | Year |
---|---|
The effect of hypolipidemic drugs on plasma lipoproteins.
Topics: Aminosalicylic Acid; Animals; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Dogs; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Neomycin; Nicotinic Acids; Rats; Sitosterols | 1977 |
Recent progress in atherosclerosis research; experimental and clinical aspects.
Topics: Animals; Anticoagulants; Arteriosclerosis; Blood Platelets; Cell Division; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Endothelium; Humans; Lipoproteins; Neomycin; Nicotinic Acids; Platelet Adhesiveness; Platelet Aggregation; Thrombosis | 1978 |
[Therapeutic orientation in the hyperlipidemias].
Topics: Cholestyramine Resin; Dextrothyroxine; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Neomycin; Nicotinic Acids; Oxandrolone; Probucol; Sitosterols; Triglycerides | 1979 |
Contemporary recommendations for evaluating and treating hyperlipidemia.
Topics: Clofibrate; Dextrothyroxine; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Lovastatin; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Phenotype; Probucol | 1986 |
The diagnosis and management of hyperlipidemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides | 1986 |
Therapy of lipid disorders.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Dextrothyroxine; Diet Therapy; Drug Therapy, Combination; Female; Hospitals, Psychiatric; Humans; Hyperlipidemias; Male; Middle Aged; Neomycin; Nicotinic Acids; Sex Factors | 1973 |
Measures to reduce the serum lipid levels in coronary heart disease.
Topics: Adult; Anticholesteremic Agents; Butyrates; Cholesterol; Cholestyramine Resin; Coronary Disease; Dextrothyroxine; Diet Therapy; Dietary Fats; Estrogens; Humans; Hypercholesterolemia; Lipids; Middle Aged; Neomycin; Nicotinic Acids; Sterols | 1968 |
[Hyperlipoproteinemia type II].
Topics: Adolescent; Adult; Cecum; Child; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Coronary Disease; Dextrothyroxine; Diet; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Ileum; Lipoproteins, LDL; Neomycin; Nicotinic Acids; Plasmapheresis; Portacaval Shunt, Surgical; Xanthogranuloma, Juvenile | 1980 |
1 trial(s) available for dextrothyroxine and framycetin
Article | Year |
---|---|
Effect of neomycin sulphate alone and in combination with D-thyroxine on serum lipoproteins in hypercholesterolaemic subjects.
Topics: Adult; Cholesterol; Dextrothyroxine; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Neomycin; Placebos; Triglycerides | 1982 |
12 other study(ies) available for dextrothyroxine and framycetin
Article | Year |
---|---|
[Drug treatment of primary hyperlipoproteinemia (author's transl)].
Topics: Anion Exchange Resins; Biguanides; Cholestyramine Resin; Clofibrate; Colestipol; DEAE-Dextran; Dextrothyroxine; Drug Therapy, Combination; Estrogens; Humans; Hyperlipidemias; Lipoproteins; Neomycin; Nicotinic Acids; Progestins; Sitosterols | 1978 |
[Treatment of hyperlipoproteinemia].
Topics: Adult; Clofibrate; Dextrothyroxine; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Neomycin; Nicotinic Acids | 1976 |
[Diet and drug therapy of hyperlipoproteinemia].
Topics: Butyrates; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Dietary Fats; Humans; Hyperlipidemias; Hypolipidemic Agents; Neomycin; Nicotinic Acids | 1975 |
Drug treatment of hyperlipidemia.
Topics: Aminosalicylic Acids; Anabolic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Estrogens; Halofenate; Humans; Hyperlipidemias; Neomycin; Nicotinic Acids; Progesterone; Sitosterols | 1976 |
Rational drug therapy of the hyperlipoproteinemias, Part II.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Female; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Probucol | 1986 |
Lipid-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Neomycin; Niacin; Pentanoic Acids; Probucol; Triglycerides | 1985 |
Xanthomas and hyperlipidemias.
Topics: Apoproteins; Arteriosclerosis; Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Diabetes Complications; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents; Hypothyroidism; Kidney Diseases; Lipoproteins; Male; Neomycin; Niacin; Obesity; Pancreatitis; Xanthomatosis | 1985 |
Hyperlipoproteinemia. Some basic concepts on diagnosis and management.
Topics: Adult; Age Factors; Aged; Aminosalicylic Acids; Blood Protein Disorders; Body Weight; Cholesterol; Chylomicrons; Clofibrate; Dextrothyroxine; Humans; Hyperlipidemias; Lipase; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Neomycin; Nicotinic Acids; Sodium; Triglycerides | 1973 |
Lipid lowering agents.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; Hyperlipidemias; Neomycin; Nicotinic Acids | 1972 |
Classification of hyperlipidaemias.
Topics: Carbohydrate Metabolism; Cholestyramine Resin; Chylomicrons; Clofibrate; Dextrothyroxine; Diabetes Mellitus; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Metabolic Clearance Rate; Neomycin; Nicotinic Acids; Obesity; Oxymetholone; Triglycerides | 1971 |
[Drug therapy of hypercholesterinemias (author's transl)].
Topics: Adult; Bezafibrate; Cholestyramine Resin; Clofibric Acid; Colestipol; Dextrothyroxine; Fenofibrate; Humans; Hypercholesterolemia; Neomycin; Nicotinic Acids; Sitosterols | 1980 |
Residues of some veterinary drugs in animals and foods. Monographs prepared by the Forty-Seventh meeting of the Joint FAO/WHO Expert Committee on Food Additives. Rome, 4-13 June 1996.
Topics: Animal Feed; Animals; Animals, Domestic; Anti-Bacterial Agents; Anti-Infective Agents; Chlortetracycline; Clenbuterol; Drug Residues; Food Additives; Food Analysis; Ivermectin; Macrolides; Neomycin; Oxytetracycline; Pyrethrins; Tetracycline; Thiamphenicol; Tylosin; Veterinary Medicine; Xylazine | 1997 |